Stay updated on Seladelpar in PBC Subjects Clinical Trial
Sign up to get notified when there's something new on the Seladelpar in PBC Subjects Clinical Trial page.

Latest updates to the Seladelpar in PBC Subjects Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page shows a new revision tag (v3.6.3) replacing the old one (v3.6.2), reflecting a backend update rather than a change to the study information.SummaryDifference0.0%

- Check21 days agoChange DetectedRevision updated from v3.6.0 to v3.6.2 in the page footer, indicating a new build of the ClinicalTrials.gov interface rather than substantive changes to the study record.SummaryDifference0.0%

- Check35 days agoChange DetectedNew user guidance sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment label was updated. A recruitment-status note (No longer looking for participants) was added and the revision label indicates an update from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page now shows Revision: v3.5.5, replacing the previous revision and signaling a minor update to the page version.SummaryDifference0.0%

- Check64 days agoChange DetectedAdded a new citation for the ASSURE interim study results (Levy et al., Am J Gastroenterol 2025) to the Publications section and removed the older interim results citation, updating the record to reflect the latest published report.SummaryDifference0.1%

- Check71 days agoChange DetectedThe page now lists 109 study locations, including a new site in Saint Petersburg, Russia. The estimated enrollment has changed from 500 to 340.SummaryDifference0.3%

Stay in the know with updates to Seladelpar in PBC Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Seladelpar in PBC Subjects Clinical Trial page.